Global Self-monitoring Blood Glucose Devices Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Self-monitoring Blood Glucose Devices market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Self-monitoring Blood Glucose Devices market."
Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.
The classification of self-monitoring blood glucose (SMBG) devices includes strips, glucose meter and lancet. The revenue proportion of strips in 2017 is about 85.08%, and the proportion is in increasing trend from 2013 to 2017.
Self-monitoring blood glucose (SMBG) devices is widely sold in public hospital, private hospital, clinics and pharmacy shops. The most proportion of self-monitoring blood glucose (SMBG) devices is sold in pharmacy shops, and the proportion in 2017is about 50.02%.
Central Thailand is the largest sales place, with a sales market share nearly 45.92% in 2017. Following Central Thailand, Northern Thailand is the second largest sales place with the market share of 24.97%.

The global Self-monitoring Blood Glucose Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Self-monitoring Blood Glucose Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Self-monitoring Blood Glucose Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Roche Roche Diagnostics
    Lifescan
    Abbott Laboratories
    Terumo
    Ascensia (Bayer)
    ...

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Strips
    Glucose Meter
    Lancet
    Other

Segment by Application
    Public Hospital
    Private Hospital
    Clinics
    Pharmacy Shops